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Discovery of long-range inhibitory signaling to
ensure single axon formation
Tetsuya Takano1, Mengya Wu1, Shinichi Nakamuta1, Honda Naoki2, Naruki Ishizawa1, Takashi Namba1,
Takashi Watanabe3, Chundi Xu1, Tomonari Hamaguchi1, Yoshimitsu Yura1, Mutsuki Amano1, Klaus M. Hahn3
& Kozo Kaibuchi1
A long-standing question in neurodevelopment is how neurons develop a single axon and
multiple dendrites from common immature neurites. Long-range inhibitory signaling from the
growing axon is hypothesized to prevent outgrowth of other immature neurites and to
differentiate them into dendrites, but the existence and nature of this inhibitory signaling
remains unknown. Here, we demonstrate that axonal growth triggered by neurotrophin-3
remotely inhibits neurite outgrowth through long-range Ca2+ waves, which are delivered from
the growing axon to the cell body. These Ca2+ waves increase RhoA activity in the cell body
through calcium/calmodulin-dependent protein kinase I. Optogenetic control of Rho-kinase
combined with computational modeling reveals that active Rho-kinase diffuses to growing
other immature neurites and inhibits their outgrowth. Mechanistically, calmodulin-dependent
protein kinase I phosphorylates a RhoA-specific GEF, GEF-H1, whose phosphorylation
enhances its GEF activity. Thus, our results reveal that long-range inhibitory signaling
mediated by Ca2+ wave is responsible for neuronal polarization.
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Neurons are highly polarized cells that have two structurallyand functionally distinct compartments: axons anddendrites1–5. Specific patterns of axonal elongation and
dendritic formation are crucial for neuronal development and
functions6–8. The processes responsible for neuronal polarization
have been extensively studied using hippocampal neurons as a
model system4, 9. Hippocampal neurons first extend several
filopodia all around the cell body (stage 1). These neurons then
generate multiple, morphologically similar immature neurites
(i.e., minor neurites). These minor neurites repeatedly extend and
retract (stage 2). A fast-growing neurite becomes an axon
(stage 3), while the remaining minor neurites continue to
undergo growth and retraction, thereby developing into dendrites
at later stages (stage 4; day 4–7). Because axonal fate is stochas-
tically determined in the absence of additional extracellular
factors, this process is called ‘‘the stochastic model’’ of neuronal
polarization.
Extracellular factors such as neurotrophins and insulin-like
growth factor-1 play a critical role in neuronal polarization10–13.
Among these factors, neurotrophins such as brain-derived
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Fig. 1 Local application of neurotrophins to an axon terminal induced remote minor neurite retraction. a Local application of neurotrophins induced remote
minor neurite retraction. PBS, NT-3, or BDNF was locally applied to the axon terminal of a stage 3 hippocampal neuron, and the images following this
application are presented. Yellow and white arrowheads indicate the retracting and resting minor neurites, respectively. Scale bar, 50 μm. b–d Time course of
changes in the lengths of the axon (blue) and minor neurites (red) from a single neuron. e, f Axonal outgrowth (PBS= 14, NT-3= 15, BDNF= 16 neurons
from three independent experiments) and minor neurite outgrowth (PBS= 45, NT-3= 39, BDNF= 31 neurites from three independent experiments) were
measured. Error bars represent SEM. *P< 0.05 and **P< 0.01
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00044-2
2 NATURE COMMUNICATIONS | 8:  33 |DOI: 10.1038/s41467-017-00044-2 |www.nature.com/naturecommunications
neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) act in
autocrine or paracrine manners to regulate neuronal polarization
in hippocampal neurons and the developing neocortex10–12.
Neurotrophins are produced from neurons and amplified in one
minor neurite, thereby leading to axon specification10–12.
Neurotrophin receptors, designated Trks, are also selectively
localized at the distal part of the axon and have been implicated
in neuronal polarization10, 12. Attenuation of neurotrophins
and/or Trks impairs neuronal polarization11, 12, indicating that
neurotrophin/Trk signaling is essential for neuronal polarization
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even in the stochastic model14–17. However, previous studies
cannot explain how neurons generate only one axon and prevent
multiple axons from forming.
We previously hypothesized that polarized neurons use a
robust long-range inhibitory mechanism to generate only one
axon, thereby determining dendritic specification1, 3. Once axonal
fate is determined, the growing nascent axon of a stage 3 neuron
is speculated to send a stronger long-range inhibitory signal to the
other minor neurites, preventing the formation of unnecessary
axons. However, the existence of long-range inhibitory signaling
has not been explored and determined. Here, we discover a
spatiotemporal long-range inhibitory signaling process that is
mediated by unique Ca2+ waves and guarantees proper neuronal
polarization.
Results
Neurotrophinson an axon cause minor neurite retraction. We
previously reported that NT-3 derived from neurons are required
for axon specification in stage 2 cultured hippocampal neurons12.
We here examined whether the local amplification of NT-3 in a
nascent axon enhances axon formation in polarized neurons
(stage 3). We found that local application of a neutralizing
antibody against NT-3 to the axon terminal inhibited axon
outgrowth (Supplementary Fig. 1), indicating that the local
amplification of NT-3 is required for axon formation in the
stochastic model. Although long-range inhibitory signals may be
produced from growing axons instage 3 cultured hippocampal
neurons, we assumed that visualizing these signals in a static state
poses practical difficulties. We hypothesized that local stimulation
of nascent axons by neurotrophins would enhance the inhibitory
signals and improve their visualization. To test this hypothesis,
we locally exposed the axon terminals to gradients of NT-3 or
BDNF for 45 min (Fig. 1a, left panel). Local application of
NT-3 or BDNF to axon terminals remarkably increased axonal
elongation compared with the control (phosphate-buffered saline
[PBS])(Fig. 1b–e). Concurrently, the terminals of most of the
minor neurites exhibited a backwards movement (Fig. 1a, yellow
arrowheads), resulting in a shortening of minor neurite length
(Fig. 1c, d, f). These results suggest that long-range inhibitory
signaling triggered by neurotrophins exists and induces the
retraction of minor neurites.
Long-range Ca2+ waves regulate minor neurite retraction. The
signals that propagate from the axon terminal to the cell body
and/or the minor neurites that induce minor neurite retraction
remain unknown. Because NT-3 is more abundant than BDNF in
the developing neocortex18, we focused on the functions of NT-3.
We previously reported that NT-3 increases Ca2+ concentrations
at the growth cones of stage 2 hippocampal neurons12. We
speculated that intracellular Ca2+ mediates long-range inhibitory
signaling. To investigate this possibility, hippocampal neurons
were loaded with a Ca2+ indicator (Cal-520 AM) and then
subjected to real-time imaging. We observed that control neurons
showed slight and transient increases in intracellular Ca2+ in the
axonal shaft (Fig. 2a and Supplementary Movie 1). Local
application of NT-3 produced transient increase in Ca2+ waves,
which were propagated from the axon to the cell body and
occasionally to the minor neurites (Fig. 2a and Supplementary
Movie 2). To determine the source of these long-range Ca2+
waves, we measured Ca2+ concentrations in the cell bodies of
hippocampal neurons treated with several specific inhibitors: The
inhibitors (including inhibitors of ryanodine receptors, the
most downstream source of cytoplasmic Ca2+) abolished the
NT-3-induced elevation of Ca2+ concentration in the cell body
(Fig. 2b). We next examined whether the long-range Ca2+
waves generated from ryanodine receptors were imprecated in
NT-3-induced minor neurite retraction. All the inhibitors
abolished the minor neurite retraction induced by NT-3 (Fig. 2c).
On the other hand, the NT-3-induced axonal elongation was
mitigated by treatment with xestospongin C (IP3 receptor
inhibitor) but not by the other inhibitors (Fig. 2d), which was
consistent with our previously reported study12. These results
indicate that long-range Ca2+ waves are generated from ryano-
dine receptors through Ca2+-induced Ca2+ release and are
required for NT-3-induced minor neurite retraction.
Calmodulin-dependent protein kinase kinase (CaMKK) and its
target calcium/calmodulin-dependent protein kinase I (CaMKI)
have been implicated in neuronal polarization12, 19, 20. Therefore,
to examine whether local stimulation of an axon with NT-3
increases CaMKI activity in the cell body of the same neuron, we
immunostained locally stimulated neurons with anti-pT177-
CaMKI, which represents the active form of CaMKI, and
anti-CaMKI antibodies. The slight phospho-CaMKI was observed
in the cell body of control neurons but not the axon and minor
neurites (Fig. 2e). The local application of NT-3 to an axon
markedly increased the phosphorylation of CaMKI in the cell
body as well as the axon but not in the minor neurites (Fig. 2e).
To examine whether the long-range Ca2+ wave that led to the
CaMKK/CaMKI pathway was responsible for NT-3-induced
minor neurite retraction, we used the following specific inhibitors:
BAPTA-AM (Ca2+ chelator), STO-609 (CaMKK inhibitor) and
KN-93 (CaMKI inhibitor). All of the inhibitors restored the
minor neurite retraction induced by NT-3 to the levels observed
in control neurons (Fig. 2f). We examined whether an increase in
intracellular Ca2+, which leads to Ca2+-induced Ca2+ release,
induces minor neurite retraction using ionomycin (Ca2+ iono-
phore)21, 22. Local application of ionomycin to the axon induced
Fig. 2 NT-3 generated long-range Ca2+ signaling from the axon to the cell body. a Long-range Ca2+ wave. The relative change in the Cal-520 emission ratio
(defined as R) was used as a measure of changes in Ca2+ concentration. The pseudocolored images represent R after local application of PBS (top) or NT-3
(bottom) to the axon (arrow). Scale bars, 50 μm. b The mean amplitude of Rtreat/R0 for 90 s during local application of NT-3 in the presence of the indicated
inhibitors (PBS= 10, NT-3= 16, xestospongin C= 9, ryanodine= 15, dantrolene= 18, SKF96365= 12 neurons from three independent experiments).
c, d The axon was exposed to NT-3 in the presence of the indicated inhibitors, and then minor neurite outgrowth (PBS= 21, NT-3= 21, xestospongin
C= 26, ryanodine= 25, dantrolene= 25, SKF96365= 24 neurites from three independent experiments) c and axonal outgrowth (PBS= 7, NT-3= 9,
xestospongin C= 9, ryanodine= 9, dantrolene= 8, SKF96365= 8 neurons from three independent experiments) d were measured. e Local application of
NT-3 increased the quantity of phospho-CaMKI in the cell body. After local application of PBS (top) or NT-3 (bottom), hippocampal neurons were
immunostained with antibodies against CaMKI (green) and phospho-Thr177 of CaMKI (magenta). The merged images (right panels) are shown. The graph
plots the fluorescence intensities of total CaMKI (green) and CaMKI phosphorylated at Thr177 (magenta) and in the line. Scale bars, 20 μm. f NT-3-induced
minor neurite retraction was abolished by Ca2+ signaling inhibitors. The axon was exposed to NT-3 in the presence of the indicated inhibitors, and minor
neurite outgrowth was measured (PBS= 27, NT-3= 31, BAPTA= 47, STO-609= 45, KN-93= 40 neurites from three independent experiments).
g, h Local application of indicated inhibitors to the axon. Minor neurite outgrowth (DMSO= 42, xestospongin C= 32, ryanodine= 37, dantrolene= 35,
SKF96365= 32 neurons from three independent experiments) g and axonal outgrowth (DMSO= 14, xestospongin C= 11, ryanodine= 13, dantrolene= 13,
SKF96365= 12 neurons from three independent experiments) h were measured. Error bars represent SEM. *P< 0.05 and **P< 0.01
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minor neurite retraction, whereas axonal elongation was not
affected (Supplementary Fig. 2a–c). We also found that local
application of ionomycin to the cell body induced minor neurite
retraction, indicating that elevation of Ca2+ concentration in the
cell body is sufficient to retract minor neurites (Supplementary
Fig. 2d, e). We next examined the effect of endogenous
long-range Ca2+ propagations on minor neurite outgrowth and
axon outgrowth using Ca2+ signaling inhibitors. Local application
of the ryanodine receptor inhibitors to axons induced minor
neurite elongation (Fig. 2g). Notably, local application of
xestospongin C but not the other inhibitors suppressed axonal
outgrowth (Fig. 2h), indicating that the local Ca2+ elevation
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through IP3 receptors is required for axon formation. We also
found that local application of BAPTA-AM or KN-93 to the
cell body induced minor neurite elongation (Supplementary
Fig. 2d, e). Altogether, these results suggest that long-range Ca2+
waves delivered from the axon terminal to the cell body are
triggered by NT-3 and negatively regulate minor neurite
outgrowth through the CaMKK/CaMKI pathway.
Polarized activation of RhoA/Rho-kinase retracts neurites. We
next explored signaling downstream of the long-range Ca2+
signaling. The Rho family GTPase RhoA has been shown to be a
negative regulator of axon formation in stage 2 neurons, through
its downstream effector Rho-kinase (ROCK)23–27. Therefore, we
examined whether local stimulation of an axon with NT-3 could
induce activation of RhoA using the intramolecular fluorescence-
resonance energy transfer (FRET) probe Raichu-RhoA, which
enables the monitoring of the balance between guanine nucleotide
exchange factor (GEF) and GTPase-activating protein (GAP)
activities and, therefore, serves as a surrogate marker for RhoA
activation28. From the first time point (approximately 3 min) after
local application of NT-3, RhoA activity markedly increased in the
cell body (Fig. 3a, arrowheads and Supplementary Movie 3 and 4),
and the increment of RhoA activity was subsequently sustained
throughout the observation period (Fig. 3b). RhoA activation was
also observed in the minor neurites of NT-3-stimulated neurons,
but not in the axon terminal (Supplementary Fig. 3). To examine
whether NT-3-induced RhoA activation was responsible for minor
neurite retraction, we used the following specific inhibitors:
C3 (RhoA inhibitor), Y-27632 (Rho-kinase inhibitor), and bleb-
bistatin (myosin II inhibitor). All the inhibitors restored the minor
neurite retraction induced by NT-3 to the levels observed in
control neurons (Fig. 3c). Because activation of RhoA in the cell
body (3–5min) after NT-3 stimulation occurred later than the
long-range Ca2+ wave (~1min) (Fig. 2a and Fig. 3a, b), we next
determined whether NT-3-induced RhoA activation was mediated
by long-range Ca2+ signaling. We found that treatment with
BAPTA-AM, STO-609 or KN-93 partially reduced NT-3-induced
RhoA activation in the cell body (Fig. 3d), indicating that the
polarized activation of RhoA/Rho-kinase is associated with long-
range Ca2+ signaling.
Optogenetic techniques are useful for analyzing the role of a
molecule by activating it at particular times and/or subcellular
locations through illumination29. We developed a photoactiva-
table Rho-kinase using the LOVTRAP optogenetic approach to
enable local activation of the kinase30. In the dark, Rho-kinase
CAT-Zdk1 was sequestered in mitochondria. During blue-light
illumination, Rho-kinase Zdk1 was released from the mitochon-
dria (Fig. 3e). Intermittent irradiation (5 s on/off cycle) for 30 min
led to stress-fiber formation in COS-7 cells and membrane
blebbing and cell contraction at the leading edge (line 2) in HeLa
cells (Supplementary Fig. 4a–d and Supplementary Movie 5). In
contrast, HeLa cells expressing a kinase-dead form of the
Rho-kinase Zdk1 were not visibly affected by irradiation
(Supplementary Fig. 4e, f). Altogether, these results validate
the use of the LOVTRAP approach as a means to manipulate
Rho-kinase activity in living cells.
Given that the minor neurite retraction induced by NT-3
(approximately 15 min) was preceded by activation of RhoA
(3–5 min) (Figs 1a and 3a, b), we used the LOVTRAP-RhoA and
LOVTRAP-Rho-kinase to evaluate whether local activation of
RhoA or Rho-kinase in the cell body could induce minor neurite
retraction. To accomplish this, we transfected LOVTRAP-RhoA,
LOVTRAP-Rho-kinase, or the kinase-dead mutant into hippo-
campal neurons. The cell bodies of the neurons were illuminated
at a wavelength of 488 nm. Neurons expressing mitochondrially
anchored LOV2 with mCherry-Zdk1or with kinase-dead
mCherry-Rho-kinase CAT-Zdk1 were not affected by blue-light
illumination (Fig. 3f–h, and Supplementary Movie 6 and
Supplementary Movie 7). Under these conditions, the photo-
activation of LOVTRAP-RhoA or LOVTRAP-Rho-kinase in the
cell body significantly induced rapid minor neurite retraction
from the first time point (approximately 10 min) (Fig. 3f, yellow
arrowheads, Fig. 3g and Supplementary Movie 8). Interestingly,
LOVTRAP-RhoA or LOVTRAP-Rho-kinase did not affect axon
length (Fig. 3h). We also investigated the effect of active RhoA/
Rho-kinase on axonal outgrowth by photoactivation of RhoA or
Rho-kinase in the distal part of the axon. We found that
photoactivation of RhoA or Rho-kinase, but not the kinase-dead
mutant of Rho-kinase, suppressed axonal elongation compared
with control neurons (Fig. 3i), indicating that axonal outgrowth is
associated with a small amount of active RhoA/Rho-kinase in the
distal part of the axon. These results suggest that polarized
activation of RhoA/Rho-kinase in the cell body induced by long-
range Ca2+ waves is sufficient to retract minor neurites but not to
affect axon outgrowth.
Rho-kinase diffuses in the neural shaft. To test whether
photoactivated Rho-kinase could diffuse from cell bodies into
short minor neurites but not into long axons, we developed a
mathematical model31. In the model, Rho-kinase undergoes
photoactivation in the cell body, passively diffuses along a neurite,
and is then inactivated by becoming trapped in mitochondria and
Fig. 3 Polarized activation of RhoA/Rho-kinase in the cell body was required for minor neurite retraction. a Spatio-temporal activation of RhoA in neurons.
PBS (top) or NT-3 (bottom) was locally applied to the axon terminal (arrow) of a neuron expressing Raichu-RhoA-CR. The pseudocolored images represent
the Raichu-RhoA-CR emission ratio. Arrowhead indicates the activation of RhoA at the cell body. Scale bar, 20 μm. b Time course of changes in FRET
efficiency in the cell body. c NT-3-induced minor neurite retraction was abolished by RhoA/Rho-kinase signaling inhibitors. The axon was exposed to NT-3
in the presence of the indicated inhibitors, and minor neurite outgrowth was measured (DMSO (PBS)= 16, DMSO (NT-3)= 22, C3= 23,Y-27632= 28,
Blebbistatin= 22 neurites from three independent experiments). d The mean amplitude of increases in FRET efficiency for 2 min during local application
were measured. The FRET efficiency in the cell body was analyzed after treatment with vehicle (control) or the indicated inhibitors in the presence of NT-3
(DMSO (PBS)= 37, DMSO (NT-3)= 37, BAPTA= 37, STO-609= 37, KN-93= 37 neurons from three independent experiments). e Cartoon
representation of the photoactivatable Rho-kinase (LOVTRAP-Rho-kinase). f Photoactivation of RhoA or Rho-kinase in the cell body induced minor neurite
retraction. The cell body of a neuron coexpressing NTOM20-LOV2 with mCherry-Zdk1 (LOVTRAP-Cont), mCherry-Zdk1-RhoA Q63L (LOVTRAP-RhoA),
mCherry-Rho-kinase CAT-Zdk1 (LOVTRAP-Rho-kinase), or mCherry-Rho-kinase CAT KD-Zdk1 (LOVTRAP-Rho-kinase KD) is illuminated in the 20-μm
square. Representative images of neurons by photoactivation for 60min are shown. Yellow and white arrowheads indicate the retracting and resting minor
neurites, respectively. g, h Time course of changes in the lengths of minor neurites g and the axon h from a single neuron expressing LOVTRAP-Cont,
LOVTRAP-RhoA, LOVTRAP-Rho-kinase, or LOVTRAP-Rho-kinase KD (LOVTRAP-Cont= 40, LOVTRAP-RhoA= 23, LOVTRAP-Rho-kinase CAT= 44,
LOVTRAP-Rho-kinase CAT KD= 36 neurites from five independent experiments). i Photoactivation of RhoA or Rho-kinase in the axon induced axonal
retraction. The distal part of the axon of a neuron expressing LOVTRAP-Cont, LOVTRAP-RhoA, LOVTRAP-Rho-kinase or LOVTRAP-Rho-kinase KD is
illuminated (LOVTRAP-Cont= 8, LOVTRAP-RhoA= 9,LOVTRAP-Rho-kinase CAT= 9, LOVTRAP-Rho-kinase CAT KD= 9 neurons from three
independent experiments). Error bars represent SEM. *P< 0.05 and **P< 0.01
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degraded (Fig. 4a). Through mathematical analysis, we found that
Rho-kinase showed greater accumulation at the tips of short
neurites (i.e., minor neurites) compared with long neurites
(i.e., an axon) (Fig. 4b). We also derived the concentration of
Rho-kinase at the neurite tip under the condition of continuous
photoactivation using the following equation:
RðLÞ ¼ C0 cosh Lffiffiffiffiffiffiffiffi
D=k
p
 !" #1
; ð1Þ
Where R, Co, Li, D, and k indicate the Rho-kinase concentration
at the neurite tip, the Rho-kinase concentration in the cell body
during photoactivation, the length of the neurite, the diffusion
rate, and the inactivation and degradation rate, respectively. This
equation indicates that as the neurite elongates, the Rho-kinase
concentration substantially decreases if it is inactivated and
degraded (Fig. 4c).
Furthermore, we examined the effect of photoactivated
Rho-kinase on neurite outgrowth by developing a mathematical
model of Rho-kinase-dependent neurite growth (Fig. 4d) as
follows:
dLi
dt
¼ μLi þ F0 þ FiGðRiÞ; ð2Þ
where t, Li, μ, Fo, Fi, and Ri indicate time, the length of the ith
neurite, the retraction coefficient, the constitutive growth force
shared by all neurites, the growth force of the ith neurite and the
Rho-kinase concentration at the tip of the ith neurite,
respectively. Ri was approximately given by Eq. 1 under the
assumption that the reaction-diffusion process of the Rho-kinase
rapidly reaches quasi-steady state (validity of this approximation
was checked by simulating reaction-diffusion of the Rho-kinase
along a growing neurite (Supplementary Fig. 5)). The first
term represents the retraction force proportional to the neurite
Ri
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length32, possibly due to membrane tension. In the third term,
G(Ri) is a decreasing Hill function that describes inhibitory
effect of the Rho-kinase on the growth force Fi via the
following: G(Ri)= Kh/(Kh + Rh), where K and h represent the
Rho-kinase concentration producing half inhibition and the
Hill coefficient describing cooperativity, respectively. Thus,
the Rho-kinase-regulated growth force increased in a neurite
length-dependent manner as a result of the decrease in
Rho-kinase concentration. We assumed that the growth
force (Fi) was regulated by a set of molecules, e.g., Shootin1
and H-Ras33, 34, accumulated at the neurite tip through active
transport. In fact, these molecules exhibit greater accumulation at
the tips of long neurites compared with short neurites33, 34.
Consistently, in our model, the longer neurite results from larger
growth force.
By simulating the dynamics of neurites in response to the
photoactivation of Rho-kinase, we produced a growth-
discouraging effect on short neurites and no effect on long
neurites (Fig. 4e), consistent with Fig. 3g, h, respectively.
Moreover, this model predicted a U-shaped relationship between
neurite length at the onset of photoactivation and neurite growth
length after photoactivation (Fig. 4f).
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To confirm this model prediction, we investigated the
relationship between the retraction induced by photoactivation
and the initial length of each axon and minor neurite. We found
that Rho-kinase-dependent growth-discouraging behavior was
increased in minor neurites that were within 75 μm of the
cell body but not in axons over 100 μm away from the cell body
(blue and red dots in Fig. 4g), which agrees qualitatively with the
model prediction (Fig. 4f). We estimated the model parameters to
fit the relationship by means of a non-linear regression method.
The model with the estimated parameters exhibited excellent
quantitative agreement with the experimental data (black line
in Fig. 4g). Using the estimated parameters, we, furthermore,
simulated the control condition, in which the Rho-kinase is not
released by photoactivation. This model then reproduced a
positive correlation between neurite length at the onset of
photoactivation and neurite growth length after photoactivation
(Fig. 4h). These results suggest that active Rho-kinase diffuses
from the cell body to short minor neurites but not to long axons
and subsequently retracts the growing minor neurites.
RhoA/Rho-kinase regulates single axon formation. Based on
the above results, we speculated that the presence of active
Rho-kinase in minor neurites prevents their outgrowth to ensure
single axon formation. To investigate the spatial distribution of
endogenous Rho-kinase, we immunostained locally stimulated
neurons with anti-Rho-kinase35. The 2.5-D reconstruction
analysis showed that, in stage 3 hippocampal neurons,
Rho-kinase was localized throughout the cytoplasm but
prominently found in minor neurites and the proximal region of
the axon (Supplementary Fig. 6a). Interestingly, when NT-3 was
locally applied to the axon, Rho-kinase was enriched in the cell
body and minor neurites compared with the axon (Supplemen-
tary Fig. 6a), which is similar to the results of the Rho-kinase
diffusion model (Fig. 4c). To examine whether local inhibition of
Rho-kinase induces minor neurite elongation, we locally exposed
the growth cone of a minor neurite of a stage 3 neuron to
Y-27632 (Fig. 5a, left panel). Local application of Y-27632 to
the minor neurite induced rapid neurite elongation in a time-
dependent manner (Fig. 5a, b, Supplementary Movie 9 and
Supplementary Movie 10). In addition, local application of C3 or
blebbistatin also induced neurite elongation (Fig. 5a, b), indicat-
ing that RhoA/Rho-kinase inhibits minor neurite outgrowth
presumably through local contractility. To determine whether
RhoA/Rho-kinase prevents minor neurites from eventually
developing into axons, hippocampal neurons were treated with
Y-27632, C3 or blebbistatin at 3 DIV and then subjected to
immunostaining with anti-Tau-1 and anti-MAP2 at 5 DIV. All of
these treatments increased the number of neurons with multiple
Tau-1-positive axons (Fig. 5c, d). Notably, these Tau-1-positive
newly formed axons grew from the distal tips of the minor
neurites of polarized neurons (Supplementary Fig. 6b). The length
of multiple axons, the longest neurite and the total number of
neurites also increased in response to the treatments (Fig. 5e–g).
These results clearly suggest that the local activity of Rho-kinase
at minor neurites is necessary to generate single axon formation
because it directly prevents multiple axon formation.
GEF-H1 is a novel substrate of CaMKI in neurons. We recently
developed a novel phospho-proteomic method called kinase-
interacting substrate screening (KISS) that can comprehensively
identify several kinase substrates36. We used this method to
identify the CaMKI substrates that lead to RhoA activation. Brain
extracts were applied to affinity beads coated with the catalytic
domain of CaMKI to form the kinase-substrate complex with
or without ATP and Mg2+ (Supplementary Fig. 7a). The
samples were digested with trypsin and subjected to liquid
chromatography/tandem mass spectrometry (LC/MS/MS).
A total of 1142 phosphorylation sites of 498 phospho-proteins
were identified. Consistent with previous reports, sequence
alignment of the predicted phosphorylation sites showed that
CaMKI phosphorylated [R]-X-X-[S/T] sequences (Supplemen-
tary Fig. 7b). Notably, numerous proteins were detected, includ-
ing small GTPase regulators (GEF/GAP), cytoskeletal proteins,
kinases, membrane proteins, and transcriptional factors (Table 1).
In this study, we focused on guanine nucleotide exchange factor-
H1(GEF-H1) as a candidate substrate of CaMKI because GEF-H1
is the only RhoA-specific regulator among these phospho-
proteins37–39. To confirm the phospho-proteomic results, we
performed an in vitro kinase assay with GEF-H1 fragments with
an N-terminal-containing C1 domain (1-84 aa), an M/1 region
(85-130 aa), an M/2 region (131-227 aa), a DH/PH domain
(228-580 aa), and a CC domain (581-985 aa) (Fig. 6a). We found
that CaMKI phosphorylated the GST-GEF-H1-M/1 regions but
not the other fragments (Fig. 6b). To identify the phosphorylation
Table 1 Candidate substrates of CaMKI in neurons
Functions Candidate substrates
GEFs Arhgef2/GEF-H1, Arfgef3, Ephexin-1
GAPs Agap2, Arfgap1, Git1, Ranbp1
Cytoskeletal proteins Add1, Add2, Camsap2, Capza2, Capzb, Cmya3, Coro7, Crmp1, Crmp3, Crmp4
Dbnl, Dnm, Enah, Epb4.1, Epb4.1l1, Epb4.9, Evl, Gfap, Lasp1, Map1a
Map1b, Map2, Map4, Map6, Map6d1, Mapre3, Mapt, Nef3, Nir2, Pacsin1
Shroom2, Tppp, Tuba1, Tuba1b, Tuba3, Tuba4, Tuba8, Tubb2a, Tubb2c, Tubb3, Tubb4, Tubb5
Protein kinases Aak1, Akt3, Araf, Camk1, Camk1g, Camk2b, Camk2d, Camkk1, Camkk2, Camkv
Cdk18, Cdk5, Erk1, Erk2, Fak2, Gsk3a, Gsk3b, Hk1, Itpk1, Itpka
Map2k4, Map3k7, Mark1, Mark2, MST3, Mylk, Pak1, Pak2, Pak7
Pctk1, Pfk-C, Pfkfb2, Pfkl, Pfkm, Pkcb, Pkcc, Pkce, Pkm2, Prkar1a, Prkar2b
Prkca, Prkra, Rps6ka2, Slk, Stk38l, Tbckl
Scaffold proteins Akap12, Alp, Homer, Shank2, Shank3
Adapter proteins Nck1, Ap2m1
Moter proteins Dctn2, Dctn4, Dhc1, Dnci1, Dncli2, Khc, Klc2
Membrane proteins Arf6, Ap1gbp1, Apba1, Atg16l1, Epn1, Hid1, Dlp1, Necap1, Ra410, Rtn3
Sec14l1, Sec16a, Sec31a, Sh3gl1, Snca, Snx1, Snx3, Snx5, Snx6, Snx17
Tbc1d10b_predicted, Tsga14, Unc13c, Vps33b, Vps52, Vps53
Transcription factors Ctbp2, Ccar1, Crtc1, Evi1, Gtf2i, Hnrpdl, Rrn3
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sites, we prepared GEF-H1-M/1 point mutants (mutated to Ala)
with potential CaMKI phosphorylation sites in this region
(Thr103, Thr114, and Ser122). Ala substitutions at Thr103
(T103A, T103A/S144A, T103A/S122A, and T103A/T114A/
S122A) abolished phosphorylation by CaMKI, but the other Ala
mutants had no effect (Fig. 6c), suggesting that CaMKI directly
phosphorylates GEF-H1 at Thr103.
To verify the phosphorylation of GEF-H1 in vivo, we
attempted to generate a phospho-specific antibody against
Thr103, and we successfully produced the anti-pT103
antibody. In immunoblotting analysis, the anti-pT103 antibody
detected GEF-H1 phosphorylation when co-expressed with
a constitutively active form of CaMKI (CaMKI-CA) but
not CaMKI-WT or the kinase-dead form of CaMKI (CaMKI-
KD) in COS-7 cells (Fig. 6d, e). In contrast, GEF-H1
phosphorylation was not detected in the T103A mutant of
GEF-H1, despite coexpression with CaMKI-CA (Fig. 6d, e). We
next explored GEF-H1 phosphorylation under more realistic
physiological conditions. The stimulation of hippocampal
neurons with NT-3 significantly increased the phosphorylation
of endogenous GEF-H1 at Thr103 (Fig. 6f, g). The NT-3-induced
phosphorylation of GEF-H1 was markedly reduced by KN-93
(Fig. 6f, g). We next investigated the spatial distribution of
phosphorylated GEF-H1 at Thr103 after local application of
NT-3. The cell bodies of the NT-3-stimulated neurons showed
significantly elevated amounts of phosphorylated GEF-H1,
whereas the axons and minor neurites did not (Supplementary
Fig. 7c–f). These results suggest that NT-3 induces the
phosphorylation of GEF-H1 at Thr103 via CaMKI in hippocam-
pal neurons.
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Fig. 6 GEF-H1 is identified as a new substrate of CaMKI in the brain. a The domain structures of GEF-H1 and its various fragments are represented. b Direct
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Phosphorylation of GEF-H1 regulates single axon formation.
To examine the involvement of GEF-H1 in NT-3-induced RhoA
activation and minor neurite retraction, we prepared short
interfering RNAs against GEF-H1 (siGEF-H1). Knockdown
efficiency was tested by immunoblotting, and the results
demonstrated that siGEF-H1#2 was more effective (Supplemen-
tary Fig. 8a). Knockdown of GEF-H1 by siGEF-H1#2 abolished
minor neurite retraction and the increment in RhoA activity in
the cell body triggered by NT-3 (Fig. 7a, b). Of note, knockdown
of GEF-H1 reduced RhoA activity even in control neurons
(Fig. 7b). These results suggest that GEF-H1 is required for
NT-3-induced minor neurite retraction and RhoA activation.
The Thr103 site of GEF-H1 is located close to the N-terminal
C1 domain, which regulates the activity of GEF-H137.
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To investigate whether the phosphorylation of GEF-H1 affects its
GEF activity, we utilized beads coated with a nucleotide-free
mutant of RhoA (RhoA-G17A) and performed an affinity
precipitation assay to specifically pull down activated GEF-
H140. Coexpression of CaMKI-CA, but not of CaMKI–WT or
CaMKI–KD, dramatically increased the amount of myc-GEF-H1
that precipitated with RhoA-G17A and stimulated the phosphor-
ylation of GEF-H1 at Thr103 (Fig. 7c, d). In addition, we
examined whether phosphorylation of GEF-H1 at Thr103 by
CaMKI enhanced its GEF activity using two GEF-H1 mutants:
T103A, which is constitutively unphosphorylated, and T103E,
which mimics the phosphorylated form. The expression of GEF-
H1–T103E significantly increased the amount of myc-GEF-H1
that precipitated with RhoA-G17A compared with GEF-H1–WT
or –T103A (Fig. 7e, f). These results suggest that CaMKI
phosphorylates GEF-H1 and activates its GEF activity on RhoA.
We next examined the effect of GEF-H1 phosphorylation by
CaMKI on neuronal polarization. We transfected myc-GEF-
H1–WT, –T103E or –T103A into hippocampal neurons at 3 DIV
and then subjected to immunostaining at 4 DIV. We found
that expression of GEF-H1–T103A, but not of GEF-H1–WT or
GEF-H1–T103E, induced multiple axon formation (Fig. 7g–k).
Furthermore, hippocampal neurons expressing GEF-H1–WT
and GEF-H1–T103E had shorter axons and minor neurites
compared with control neurons, whereas neurons expressing
GEF-H1–T103A had significantly increased axon and total
neurite lengths (Fig. 7i–k).
We next examined the effect of GEF-H1 knockdown on
neuronal polarization. We prepared pSico-mCherry-GEF-H1
(shGEF-H1), which allowed the expression of short hairpin
RNA (shRNA) against GEF-H1 under the control of Cre
recombinase12, 41. Transfection of shGEF-H1#1 and shGEF-
H1#2 with Cre effectively decreased the expression level of
GEF-H1 in Neuro2a cells and hippocampal neurons (Supple-
mentary Fig. 8b, c). Knockdown of GEF-H1 at 3 DIV induced the
formation of multiple Tau-1-positive axons in hippocampal
neurons (Supplementary Fig. 8d, g) and increased the longest
neurite length and total neurite length compared with
control neurons (Supplementary Fig. 8h, i). We next performed
rescue experiments in GEF-H1-depleted neurons with
shRNA-resistant forms of GEF-H1 (GEF-H1 Res), which restored
the expression of GEF-H1 in Neuro2a cells (Supplementary
Fig. 8e). In hippocampal neurons, expression of GEF-H1–WT Res
or –T103E Res in GEF-H1-depleted neurons reversed the
knockdown effects by leading to the formation of multiple axons
and increasing axon and total neurite lengths to the levels
observed in control neurons (Supplementary Fig. 8f–i). In
contrast, GEF-H1–T103A Res did not recover the knockdown
effects (Supplementary Fig. 8f–i). These results suggest that
GEF-H1 and its phosphorylation at Thr103 are important for
single axon formation in hippocampal neurons.
Phosphorylation of GEF-H1 regulates polarity in vivo. We
further investigated the role of GEF-H1 in neuronal polarization
in vivo using an in utero electroporation system to introduce
GEF-H1 and shRNA into pyramidal neurons41, 42. Pyramidal
neurons first extend multiple minor processes and are called
multipolar (MP) cells in intermediate zone (IZ). These MP cells
subsequently transform into bipolar (BP) cells with a trailing
process and a leading process, which finally develop into an axon
and a dendrite, respectively2, 3. BP cells are completely polarized
and migrate toward the cortical plate (CP). We transfected
the E13.5 neocortex with pTα-LPL, pTα-LPL-GEF-H1–WT,
pTα-LPL-GEF-H1–T103E, or pTα-LPL-GEF-H1–T103A,
together with pTα-Cre and pTα-LPL-Lyn-EGFP. The majority of
the control cells had entered into the CP, whereas most of the
GEF-H1–WT-, –T103E-, or –T103A-expressing pyramidal cells
failed to acquire a BP morphology and migrate into the
(Fig. 8a–e). Notably, the GEF-H1–T103E-expressing pyr-
amidal cells exhibited an abnormal round morphology, whereas
the GEF-H1–T103A-expressing pyramidal cells showed impaired
formation of leading processes (Fig. 8a, d, e). We also found that
most of the shGEF-H1-expressing pyramidal cells failed to
acquire a BP morphology and enter the CP (Fig. 8f–j). The
knockdown phenotype was rescued by coelectroporation with
GEF-H1–WT Res but not with –T103E Res or –T103A Res
(Fig. 8f–j). GEF-H1–T103E Res-expressing pyramidal cells did
not show restored trailing process formation (Fig. 8f, i, j). In
contrast, GEF-H1–T103A Res-expressing pyramidal cells did not
show restored leading process formation (Fig. 8f, i, j). These
findings suggest that GEF-H1 and its phosphorylation at Thr103
are important for neuronal polarization in the developing
neocortex.
Discussion
We succeeded in identifying a long-range inhibitory signaling
pathway that is enhanced by the local application of NT-3 onto a
nascent axon (Supplementary Fig. 9). Because this signaling is
transient, identifying the inhibitory machinery posed substantial
technical challenges43, 44, as the Ca2+ waves could only be
occasionally and transiently observed in axons under static
conditions (Fig. 2 and Supplementary Movie 1). In the absence of
exogenous neurotrophins, cultured neurons stochastically extend
one axon and other minor neurites that never develop into axons
(the stochastic model)1–5, 44–48. Thus, typical neurons could
possess long-range inhibitory signaling for a single axon forma-
tion without the need for exogenous factors. Consistently, the
attenuation of long-range Ca2+ propagations from the axon to the
cell body and the subsequent CaMKI activity in the cell body
induced minor neurite elongation (Fig. 2 and Supplementary
Fig. 2). Moreover, local inhibition of Rho-kinase in minor
neurites in stage 3 neurons induced rapid neurite elongation and
Fig. 7 Phosphorylation of GEF-H1 by CaMKI increased its GEF activity. a NT-3-induced minor neurite retraction was abolished by knockdown of GEF-H1
(siCont/PBS= 29, siCont/NT-3= 26, siGEF-H1#2/PBS= 23, siGEF-H1#2/NT-3= 26 neurites from three independent experiments). b The increase in
FRET efficiency in the cell body induced by NT-3 was abolished by knockdown of GEF-H1 (siCont/PBS= 5, siCont/NT-3= 8, siGEF-H1#2/PBS= 6,
siGEF-H1#2/NT-3= 15 neurons from three independent experiments). c CaMKI increased the GEF activity of GEF-H1. GEF-H1 was co-transfected with
myc-CaMKI-WT, -CA or –KD into COS-7 cells. The cell extracts were incubated with GST-RhoA-G17A-bound beads. Active GEF-H1 was pulled down and
detected by immunoblotting with anti-myc (top). Total GEF-H1 and CaMKI were detected by immunoblotting with anti-myc (middle and bottom,
respectively). d Bar graphs indicate the ratio of GEF-H1 activity. e The phospho-mimic mutant GEF-H1 exhibited an increment in GEF activity. Cell lysates
expressing GEF-H1–WT, –T103A or –T103E were incubated with GST-RhoA-G17A-bound beads. Active (top) or total (bottom) GEF-H1 was detected by
immunoblotting with an anti-myc antibody. f Bar graphs indicate the ratio of GEF-H1 activity. g myc-GST (Cont), myc-GEF-H1–WT, –T103A or –T103E was
transfected into neurons at 3 DIV. Representative images of the neurons at 4 DIV are shown. Scale bars represent 100 μm. h The percentages of neurons
with multiple Tau-1-positive axons. i Bar graphs indicate the ratio of multiple axonal lengths. j, k The length of the longest neurite i and the total neurite
length j were determined (GST= 86, GEF-H1 WT= 90, GEF-H1 T103E= 88, GEF-H1 T103A= 90 neurons from three independent experiments). Error bars
represent SEM. *P< 0.05 and **P< 0.01
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subsequent multiple axon formation (Fig. 5). These results clearly
indicate that long-range inhibitory signaling plays a critical role in
neuronal polarization not only in the NT-3-stimulated model but
also in the stochastic model.
CaMKI plays a crucial role in the establishment of neuronal
polarity12, 19, 20. However, the substrates used by CaMKI during
neuronal polarization have not yet been identified. In this study,
we found that CaMKI phosphorylated GEF-H1 at Thr103, which
is located close to the C1 domain. The phosphorylation of
GEF-H1 by CaMKI enhanced its GEF activity and suppressed
axon formation in vitro and in vivo. GEF-H1 is associated with
microtubules through the C1 domain and is activated following
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its release from microtubules37, 38. In addition, several GEFs, such
as Vav2 and Tiam1, contain regulatory domains that inhibit
activity through an intramolecular interaction, and the dissocia-
tion of this interaction through a conformational change leads
to GEF activation49, 50. The GEF-H1 phosphorylated by
CaMKI may be activated by its release from microtubules and/or
by the halting of auto-inhibition. On the other hand, the
non-phosphorylation mutant of GEF-H1 induced the formation
of multiple axons (Fig. 7), indicating that GEF-H1 maintains
single axon formation depending on its phosphorylation
state. However, we cannot exclude the possibility that the
non-phosphorylation mutant of GEF-H1 would have functioned
as a dominant-negative factor.
The subcellular polarity of the small GTPases plays a critical
role in cell polarization23–27. We found that NT-3-induced Ca2+
waves led to the polarized activation of RhoA/Rho-kinase in the
cell bodies of hippocampal neurons. Importantly, GEF-H1
knockdown fully inhibited the polarized activation of RhoA,
indicating that GEF-H1 mediates this polarized activation. The
mechanism by which GEF-H1 regulates polarized RhoA activity
in neurons remains unknown. One possibility is that the
polarized activity of RhoA results from the difference in
phosphorylation states of GEF-H1 in neurons. Indeed,
phosphorylation of GEF-H1 at Thr103 was increased by NT-3
in the cell body but not in the axon or minor neurites
(Supplementary Fig. 7). Another possibility is that GEF-H1 may
be specifically inactivated in the axon by PKA because PKA has
been activated in the growing axon by neurotrophins51, 52. RhoA/
Rho-kinase activity in the cell body is important for preventing
the formation of unnecessary axons. We found that photo-
activation of RhoA or Rho-kinase in the cell body resulted in
rapid minor neurite retraction but not axon retraction. Addi-
tionally, our computational modeling helps explain how active
Rho-kinase diffuses from the cell body to short minor neurites
but not to long axons and subsequently retracts growing minor
neurites to prevent multiple axon formation.
Rho-kinase governs a wide variety of cellular events such as
actin filament and microtubule dynamics that regulate axon
formation5, 46, 51 through several of its substrates, including LIM
kinase, CRMP-2 and Tau53–55. In addition, local inhibition of
myosin II induced minor neurite elongation to some extent,
indicating that the role of Rho-kinase in neuronal polarization is
partly mediated by contractility. Interestingly, local stimulation
with NT-3 induced continuous activation of RhoA in minor
neurites (Supplementary Fig. 3). We previously reported that
Rho-kinase phosphorylates and inactivates p190RhoGAP, thereby
leading to sustained activation of RhoA56. Rho-kinase also
inactivates Rac1 through phosphorylation of Par3 and Rac
GEFs (STEF/Tiam)1, 3, 57. Following Rho-kinase activation by
long-range inhibitory signaling, the activated RhoA may be
sustained and diffused by Rho-kinase-dependent inactivation of
RhoGAP, ultimately guaranteeing neuronal polarity through
multiple pathways in minor neurites.
We previously reported that CaMKI and RhoA/Rho-kinase
regulates MP-to-BP transition and proper neuronal entry into
CP12, 27. However, the regulatory interaction between CaMKI and
RhoA/Rho-kinase during neuronal polarization in vivo remains
undetermined. Here, we focused on GEF-H1 functions and found
that GEF-H1 and its phosphorylation were required for the
MP-to-BP transition and the subsequent neuronal migration
(Fig. 8). The expression of GEF-H1-T103E impaired MP-to-BP
transition in vivo, which was consistent with previous results of
active CaMKI and RhoA12, 58. We recently found that expression
of the dominant-negative RhoA or Rho-kinase also impairs
MP-to-BP transition and neuronal migration27. The appropriate
activity of RhoA/Rho-kinase is vitally essential for neuronal
polarization, and, therefore, might be properly regulated by
CaMKI-mediated phosphorylation of GEF-H1 in the developing
neocortex. Interestingly, GEF-H1-T103A-expressing pyramidal
cells formed unidentified multiple processes, which were shorter
than trailing processes, resulting in an interruption of the leading
process (future dendrite) formation in vivo, which was similar to
our in vitro findings. Thus, Ca2+/CaMKI/GEF-H1/RhoA/Rho-
kinase signaling is a novel signaling pathway that function in
long-range inhibition to establish and maintain neuronal polarity
during neuronal development.
Methods
Plasmid construction. Mouse GEF-H1 was amplified by PCR and subcloned into
pCAGGS and pTα-LPL vectors. The mutants of GEF-H1-T103A, GEF-H1-T114A,
GEF-H1-S122A, GEF-H1-T103A/T114A, GEF-H1-T103A/S122A, GEF-H1-
T114A/S122A, GEF-H1-T103A/T114A/S122A, and GEF-H1-T103E were gener-
ated using a site-directed mutagenesis kit (Stratagene) (Supplementary Table 1).
cDNA fragments encoding GEF-H1 mutants (GEF-H1 C1, GEF-H1 M/1, GEF-H1
M/2, GEF-H1 DH/PH, and GEF-H1 CC) were subcloned into pGEX vector (GE
Healthcare) (Supplementary Table 1). GST-tagged proteins were produced in BL21
(DE3) Escherichia coli cells and purified on glutathione–Sepharose 4B beads (GE
Healthcare). The cDNAs encoding wild-type CaMKIa, a constitutively active
cytosolic form of CaMKIa (CaMKIa-293NES), and a kinase-dead form of CaMKIa
(CaMKIa-293NES-KA) were obtained as previouslydescribed12, 20. pCAGGS-
Raichu-RhoA-CR was a gift from Michael Lin as previously described (Stanford
University, CA) (plasmid #40258, Addgene)27, 28. NTOM20-mVenus-LOV2 was
obtained as previously described30. cDNAs encoding mCherry-Zdk1, mCherry-
Zdk1-RhoA Q63L, mCherry-Rho-kinase CAT-Zdk1, and mCherry-Rho-kinase
CAT KD-Zdk1 were subcloned into pTrix and pCAGGS vectors. The target
sequences for siGEF-H1#1 and siGEF-H1#2 were as follows: 5′-CUGAUU-
GUCCUUACCAGUUTT-3′ and 5′-GAAGCAAGAUGUCAUCUAUTT-3′,
respectively. pSico-mCherry was generated by inserting mCherry in place
of EGFP as previously described12. The mouse GEF-H1 shRNA plasmid was
generated by inserting the annealed oligonucleotides into apSicovector59, 60.
The target sequences for shGEF-H1 #1 and shGEF-H1#2 were as follows:
5′-GGGCTGCGGTTGCTTCTGTAA-3′ and 5′-GGGATGCTGGAA-
GAGTTGCAG-3′, respectively24. shRNA-resistant GEF-H1 was generated by
changing the targeted sequence of shGEF-H1 #2 to the sequence 5′-GGAATGC-
TAGAAGAATTGCAG-3′ by PCR-based site-directed mutagenesis. All constructs
were confirmed by DNA sequencing. pEF-BOS-GST-RhoA-G17A was used for the
pull-down assay40, 61.
Fig. 8 The role of GEF-H1 in neuronal polarization in vivo a pTα-LPL-Lyn-EGFP was coelectroporated with Tα-Cre and pTα-LPL (control),
pTα-LPL-GEF-H1–WT, –T103E, or –T103A into cerebral cortices at E13 followed by fixation at E16. Coronal sections were prepared and immunostained with
an anti-EGFP antibody (green). Nuclei were stained with Hoechst 33342 (blue). The tracing images depict EGFP-labeled cells (bottom panels). Scale bars,
100 μm. b Quantification of the distributions of EGFP-positive cells in distinct regions of the cerebral cortex (CP and IZ). c Percentages of EGFP-positive
cells with bipolar (BP) or multipolar (MP) morphologies in the cerebral cortex. d, e Percentages of trailing process-positive d or leading process-positive
e neurons (pTα-LPL-EGFP= 6, pTα-LPL-GEF-H1-WT= 9, pTα-LPL-GEF-H1-T103E= 9, pTα-LPL-GEF-H1-T103A= 4 brains from three independent
experiments). f pSico-mCherry-shGEF-H1 #1 or pSico-mCherry-shGEF-H1 #2 was coelectroporated with Tα-Cre and Tα-LPL-Lyn-EGFP or shRNA-resistant
forms of GEF-H1 into cerebral cortices at E13 followed by fixation at E16. Coronal sections were prepared and immunostained with an anti-EGFP antibody
(green). Nuclei were stained with Hoechst 33342 (blue). The tracing images showed the EGFP-labeled cells (bottom panels). Scale bars represent 100 μm.
g Quantification of the distributions of EGFP-positive cells in distinct regions of the cerebral cortex (CP and IZ). h Percentages of EGFP-positive cells with
bipolar (BP) or multipolar (MP) morphologies in the cerebral cortex. i, j Percentages of trailing process-positive i or leading process-positive j neurons
(pSico-mCherry= 4, pSico-mCherry-shGEF-H1 #1= 8, pSico-mCherry-shGEF-H1 #2= 4, pTα-LPL-GEF-H1-WT Res= 5, pTα-LPL-GEF-H1-T103E Res= 13,
pTα-LPL-GEF-H1-T103A Res= 10 brains from three independent experiments). Error bars represent SEM. *P< 0.05 and **P< 0.01
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Antibodies. The following antibodies and materials were used: a monoclonal
rabbit anti-GEF-H1 antibody (1:1000, Cell Signaling, 4076); a polyclonal rabbit
anti-c-myc antibody (1:1000, Santa Cruz Biotechnology, sc-789); a monoclonal
mouse anti-myc antibody (9E10, 1:1000, sc-40), a monoclonal mouse anti-α-
tubulin antibody (DM1A, 1:2000, T9026), a monoclonal mouse anti-GST antibody
(1:1000, Sigma, G 1160), a monoclonal mouse anti-Tau-1 antibody, (1:2000, Mil-
lipore Bioscience Research Reagents, MAB3420) a polyclonal anti-MAP2 antibody
(1:1000, Chemicon, AB5622), monoclonal mouse anti-class III β-tubulin and
polyclonal rabbit anti-class III β-tubulin antibodies (Tuj1, 1:2000, Covance,
MMS-435P), a monoclonal mouse anti-GFP antibody (1:1000, Roche Diagnostics,
11814460001), a polyclonal rabbit antibody against GEF-H1 phosphorylated at
Thr-103 was produced against the phosphopeptide (Cys-Leu98-Leu-Arg-Asn-Asn-
phospho-Thr103-Ala-Leu-Gln-Ser-Val-Ser109) by Wako, a polyclonal anti-NT-3
anti body (1:500, Promega, G165A), a monoclonal anti-CaMKI antibody (1:500,
Sigma, WH0008536M1), and a polyclonal anti–phospho-CaMKI antibody (1:1000,
Abcam, ab62215).
Primary hippocampal neuron cultures and immunofluorescence analysis. All
animal experiments were performed according to the guidelines of the Institute for
Developmental Research and were approved by The Animal Care and Use
Committee of Nagoya University. Pregnant ICR mice were purchased from SLC
Japan. Hippocampal neurons were prepared from E15 mouse embryos with papain
as previously described7, 62. Briefly, neurons were seeded on coverslips or dishes
coated with poly-D-lysine (Sigma) and cultured in neurobasal medium (Invitrogen)
supplemented with B-27 (Invitrogen) and 1 mM GlutaMAX (Invitrogen) to
observe morphology and perform immunoblot analysis. Neurons were subjected
to local application of various factors through micropipettes. Neurons were
transfected using Lipofectamine 2000 or Lipofectamine 3000 according to the
manufacturer’s instructions. Neurons were treated with Y27632 (20 μM), RhoA
inhibitor I (4 μg/ml, cytoskeleton) or blebbistatin (50 μM) for 48 h. Neurons were
fixed with 4% paraformaldehyde in PBS for 20 min at room temperature and
permeabilized in PBS containing 0.1% Triton X-100 and 5% normal goat serum for
20 min. The cells were probed with the indicated primary antibodies followed by
secondary antibodies conjugated to Alexa-488, Alexa-546, or Alexa-647 (Invitro-
gen) as previously described62–64. Fluorescence images were acquired with LSM
780 or LSM5 Pascal microscopes constructed around an Axio Observer Z1 or
Axiovert 200M with Plan-Apochromat 20 × (numerical aperture [NA] 0.75),
Plan-Apochromat 20 × (NA 0.8), C-Apochromat 40 × (NA 1.2), or Plan
Apochromat 63 × (NA 1.40) lenses under the control of LSM software (Carl Zeiss).
A neuron was considered to have an axon if one process was at least twice as long
as any other process, and a neuron was considered Tau-1-positive, as previously
described7.
Local application. Local application of NT-3 (50 μg/ml in a micropipette,
PeproTech), anti-NT-3 (500 μg/ml), ionomycin (1 mM), xestospongin C (2 mM),
dantrolene (20 mM), SKF96365 (3 mM), ryanodine (100 mM), BAPTA-AM
(5mM), KN-93 (1 mM), Y27632 (20 mM), RhoA inhibitor I (4 mg/ml, Cytoske-
leton), or Blebbistatin (50 mM) was performed as previouslydescribed12, 65 with
some modifications. Briefly, an axon or a selected minor neurite was exposed to the
factors for 45 or 60 min. Differential interference contrast images were acquired
every 5 min with an UplanApo 20 × 1.6 (numerical aperture (NA) 0.75) objective
(Olympus) on an inverted microscope (IX81-CSU, Olympus) equipped with an
Evolve 512 EMCCD camera (Photometrics) controlled by MetaMorph software
(Molecular Devices). In some experiments, the following reagents were applied to
the culture medium at least 30 min before the application of the NT-3 gradients as
previouslydescribed12: 2 μM xestospongin C, 20 μM dantrolene, 3 μM SKF96365,
100 μM ryanodine (Alomone Labs), 5 μM BAPTA-AM (Invitrogen), 1 μM KN-93
or 5 μM STO-609.
Ca2+ imaging. Hippocampal neurons were loaded with Cal-520TM (2 μM, AAT
Bioquest) and F-127 (0.04%, Invitrogen) for 30 min before local application. The
images were excited at a wavelength of 492 nm and acquired every 2 s with an
UplanApo 20 × 1.6 (numerical aperture (NA) 0.75) objective (Olympus) on an
inverted microscope (IX81-CSU, Olympus) equipped with an Evolve 512 EMCCD
camera (Photometrics) controlled by MetaMorph software (Molecular Devices).
Next, we calculated the imaging ratio for the identified cell region of interest in the
field of view. The Ca2+ concentration (Rtreat/R0) was normalized against the
baseline pre-stimulation value. The amplitudes of the NT-3-induced increases in
the Ca2+ concentration were defined as the mean of Rtreat/R0 during the period
from 50 to 80 s after local application.
Fluorescence-resonance energy transfer. FRET images of neurons expressing
Raichu-RhoA-Clover-mRuby2 (FRET probe) were acquired every 20 s with an
UplanApo 20 × 1.6 (numerical aperture (NA) 0.75) objective (Olympus) on an
inverted microscope (IX81-CSU, Olympus) equipped with an Evolve 512 EMCCD
camera (Photometrics) controlled by MetaMorph software (Molecular Devices).
FRET and donor emission images were acquired using the following filters
(ex, excitation; em, emission): ex 485/30 nm and em 530/40 nm for Clover and
ex 485/30 nm and em 595/70 nm for Clover-mRuby2 FRET. The ratio of mRuby2
to Clover, as determined by MetaMorph, represented the FRET efficiency, which
represented the ratio of the RhoA activity. The amplitudes of the NT-3-induced
increases in FRET efficiency were defined as the mean during the period from 3 to
15 min after local application of NT-3.
LOVTRAP-Rho-kinase. LOV-based photoactivation analysis was performed as
previously described with some modification30. Briefly, hippocampal neurons were
seeded on glass-bottom dishes and then transfected with pCAG-myc-NTOM20-
LOV2 and pCAG-myc-mCherry-Zdk1, pCAG-myc-mCherry-Zdk1-RhoA Q63L,
pCAG-myc-mCherry-Rho-kinase CAT-Zdk1, or pCAG-myc-mCherry-Rho-kinase
CAT KD-Zdk1 at 2 to 3 DIV using Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s protocols. Confocal images were recorded for 80 min with an
LSM780 built around an Axio Observer Z1 with a Plan Apochromat 63 × oil
(NA 1.40) (Carl Zeiss) lens. The cell bodies of mCherry-positive neurons were
illuminated with a 20-um square of blue light from a 488-nm laser for 5 s between
each pair of image acquisitions.
Mathematical model for the diffusion of Rho-kinase along the neurites. The
dynamics of the spatial distribution of Rho-kinase along a neurite were described as
follows:
∂C
∂t
¼ D ∂
2C
∂x2
 kC; ð3Þ
with boundary conditions of C(x= 0, t) = Cs(t) and ∂C/∂x|x=L= 0, where t, x, L, C,
Cs, D and k indicate time, the space coordinate along a neurite, the length of the
neurite, the concentration of Rho-kinase along the neurite, the concentration of
Rho-kinase in the cell body, the diffusion rate, and the inactivation and degradation
rates, respectively. The time-dependent concentration of Rho-kinase in the soma is
represented by Cs(t) = CoP(t), where Co and P(t) indicate the Rho-kinase
concentrations in the cell body during photoactivation and the time course of
photoactivation, in which the binary variables 0 and 1 represent without and with
photoactivation, respectively.
Notice that this model did not include active transport of Rho-kinase from the
cell body to neurite tips, in contrast to previous models31, 33, 34, 66. According to
our previous theoretical work31, actively transported molecules are more
accumulated in longer neurites. If Rho-kinase is so, growth of longer neurites is
more inhibited by active Rho-kinase. This is inconsistent with our experimental
finding that growth of shorter neurites is more inhibited by photoactivation of
Rho-kinase (Fig. 3g, h). Moreover, in our imaging, we did not observe active
transport of Rho-kinase. Thus, we did not take account for active transport of
Rho-kinase.
The steady state distribution of Rho-kinase along a neurite was described by
∂C/∂x2= (k/D)C, which was calculated as follows: C(x) =A exp(−(k/D)1/2x) +
B exp((k/D)1/2x), where A and B represent constants. The general solution
satisfying the boundary conditions was as follows:
CðxÞ ¼ C0
1þ expð2 ffiffiffiffiffiffiffiffiffiffiffik=DLp Þ expð
ffiffiffiffiffiffiffiffiffiffiffi
k=Dx
p
Þ þ expð2
ffiffiffiffiffiffiffiffiffiffiffi
k=DL
p
Þ expð
ffiffiffiffiffiffiffiffiffiffiffi
k=Dx
p
Þ
h i
;
ð4Þ
Next, we calculated the amount of Rho-kinase at the neurite tip according
to C(L), which is described in equation (1) in the text.
Model parameters. The initial neurite length was set as (Fo + cFi)/μ, where c is a
parameter (0≦ c≦ 1). The parameter values used were D= 20 (μm2 s−1), k= 0.02
(s−1), μ = 0.03 (min−1), Fo= 0.01(μms−1), K/Co= 0.4, h= 2 and c= 0.95 (Fig. 4b, c,
e, c). It has been reported that the diffusion rate of protein in mammalian cell
cytoplasm is 20~100 (μm2 s−1)67, and therefore, we adopted D= 20 (μm2 s−1). In
response to photoactivation, Rho-kinase is rapidly released within 1 min, which
means that its time constant is approximately 60 s, (i.e., k= 1/60≒ 0.02 s−1). The
value of μ was determined by the retraction speed of the neurite during photo-
activation (Fig. 3g, h). Values of other parameters (Fo, K/Co, h, and c) were
heuristically selected but estimated to fit the experimental data (Fig. 4h); estimated
values were Fo= 0.0134 (μm s−1), K/Co= 0.2756, h = 2.7888 and c= 0.95.
Bottom-up derivation of equation 2. The neurite growth was modeled by
dLi
dt
¼ vi; ð5Þ
m
dvi
dt
¼ λvi  κLi þ f0 þ fiGðRiÞ; ð6Þ
where Li and vi indicate the length and growth speed of the ith neurite, respectively;
m, λ, and κ indicate the mass of the growth cone, the viscosity coefficient and the
spring constant for the retraction force, respectively; fo, fi, and Ri indicate the
constitutive growth force, the Rho-kinase-regulated growth force of the ith neurite
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and the Rho-kinase concentration at the tip of the ith neurite as given by
equation (1), respectively. If m<< λ, vi rapidly reaches quasi-steady state,
vi ¼ κLi þ fo þ fiGðRiÞ
λ
: ð7Þ
Then, equation becomes
dLi
dt
¼  κ
λ
Li þ fo
λ
þ fi
λ
GðRiÞ: ð8Þ
This equation is namely equation (2), where κ/λ, fo/λ, and fi/λ were rewritten as
μ, Fo, and Fi, respectively.
Reaction-diffusion simulation with a growing neurite. To validate our
approximation of Ri in equation (2), we simulated reaction-diffusion of the
Rho-kinase with a moving boundary caused by neurite growth, i.e., ∂C/∂x|x=L(t)= 0.
Suppose a spatial scaling of y= x/L(t), where x 2 ½0; LðtÞ and y 2 ½0; 1. Then,
equation (2) was transformed to
∂C
∂t
¼ D
LðtÞ2
∂2C
∂y2
 kC ð9Þ
with boundary conditions of C(y= 0, t)= Cs(t) and ∂C/∂y|y=1= 0. Based on
equation (9), we performed an exact simulation of the reaction-diffusion
process coupled with neurite growth. We then confirmed that the steady state
approximation was valid (Supplementary Fig. 5d–f).
Non-linear regression method. We performed a regression in which the
parameters in equations (1 and 2), denoted in total by θ, were estimated by
non-linear regression to minimize the quadratic error function as follows:
EðθÞ ¼ 1
2
XM
n¼1
tn  f ðzn; θÞf g2; ð10Þ
Where f(zn; θ) is the simulated retraction length depending on the initial length
of the neurite, as shown in Fig. 4f, which we aimed to fit to the experimental data;
zn and tn are the observed length (i.e., minor neurites and axon) at the onset of
photoactivation and the observed retraction length after photoactivation,
respectively, of the nth neurite; andM indicates the total number of neurites among
all neurons. We used a simplex Nelder-Mead algorithm to minimize the error
function (10).
Mass spectrometry (KISS method). Rat brain lysate was incubated with
glutathione Sepharose beads coated with GST-CaMKI-cat (500 pmol). The proteins
bound to CaMKI-cat were incubated with or without ATP and Mg2+ and then
denatured with guanidine hydrochloride and digested with trypsin for 16 h at 37 °C
following reduction, alkylation, demineralization, and concentration. The phos-
phopeptides were concentrated using a Titansphere Phos-TiO Kit (GL Sciences)
according to the manufacturer’s instructions. Nanoelectrospray tandem mass
analysis was performed using a Q Exactive mass spectrometry system (Thermo
Fisher Scientific Inc.) combined with an HTC-PAL autosampler and a Paradigm
MS4 HPLC System (Michrom BioResources Inc.) using a C18 reverse-phase
column and a Michrom ADVANCE Plug-and-Play NanoSpray Source. A peak list
was generated and calibrated using MaxQuant software. Database searches were
performed against the complete proteome set of Rattus norvegicus in UniProt KB
2014_07 concatenated with reverse copies of all sequences. The ion intensities of
the identified peptides in the phosphorylated sample were compared with those of
the nonphosphorylated sample, and the phosphorylation sites exhibiting greater
than fivefold increases in ion intensity were regarded as candidate substrates36.
In vitro phosphorylation assay. The phosphorylation assay was performed as
previously described68. Briefly, kinase reactions for CaMKI were performed
in 100 μl of a reaction mixture (50 mM Tris/HCl, pH 7.5, 1 mM EDTA, 1 mM
EGTA, 1 mM DTT, 5 mM MgCl2, and 100 μM [γ- 32P] ATP [1-20 GBq/mmol]),
with 0.05 μM of the catalytic domain of CaMKI and purified GST-GEF-H1
mutants for 30 min at 30 °C. The reaction mixtures were then boiled in sodium
dodecyl sulfate (SDS) sample buffer and subjected to SDS-polyacrylamide gel
electrophoresis (PAGE) and silver staining. The radiolabeled proteins were
visualized with an image analyzer (BAS1500; Fuji). Full-length blots are shown
in Supplementary Fig. 10.
Analysis of GEF activity of GEF-H1. The guanine nucleotide exchange activity of
GEF-H1 was measured as previously described with some modifications40, 61. In
brief, GST-RhoA-G17A was transfected into COS-7 cells (obtained from RIKEN
Cell Bank, RCB0539). The cells were lysed in 10 mM HEPES, pH 7.5; 150 mM
NaCl; 1 mM MgCl2; 1 mM EGTA; 0.2% Triton-X; protease inhibitor mixture
(cOmplete Mini EDTA-free, Roche); and phosphatase inhibitor mixture
(PhosSTOP, Roche). The cell lysate, which was obtained by centrifugation at
15,000×g for 10 min at 4 °C, was incubated with glutathione Sepharose beads
(GE Healthcare). After centrifugation at 2500×g for 5 min, the GST-RhoA-G17A-
glutathione Sepharose beads were incubated at 4 °C in extracts of COS-7 cells
expressing GEF-H1. SDS-PAGE and immunoblotting were performed as
previously described7, 63. GEF-H1 band intensities were quantified using ImageJ
software. Full-length blots are shown in Supplementary Fig. 10.
In utero electroporation. In utero electroporation was performed as previously
described12, 27, 41 with some modifications. pTα-1-LPL-Lyn-EGFP (2 μg/μl) was
co-microinjected with pTα-1-Cre (0.01 μg/μl) and pTα-LPL-GEF-H1–WT,
–T103A or –T103E (4 μg/μl) into the lateral ventricle of E13 embryos. To achieve
GEF-H1 knockdown, pTα-LPL-Lyn-EGFP was coinjected with pSico-mCherry-
shGEF-H1#1 or - shGEF-H1#1 (3 μg/μl), and pTα-Cre (0.05 μg/μl). After plasmid
injection into the lateral ventricle of the embryos at E13, electric pulses (50-ms
square pulses of 32 or 40 V with 950-ms intervals) were applied to the embryos.
Immunohistochemistry and quantitative analysis. Immunohistochemistry
was performed as previously described12, 27, 41. Briefly, brains were fixed in
4% paraformaldehyde at E16.5 and coronally sectioned with a cryostat (Leica
Microsystems) at a thickness of 60 μm. The slices were incubated with primary
antibodies diluted in PBS containing 1% bovine serum albumin (BSA) and 0.01%
Triton X-100 at 4 °C overnight followed by Alexa Fluor 488- or Alexa Fluor
555-conjugated secondary antibodies diluted in PBS containing 1% BSA and
0.01% Triton X-100 for 1 h at room temperature. The nuclei were visualized
by staining with Hoechst 33342 (Invitrogen). Confocal images were recorded
using an LSM 780 built around an Axio Observer Z1 with Plan-Apochromat
20 × (numerical aperture (NA) 0.75), C-Apochromat 40 × (NA 1.2), or Plan
Apochromat 63 × (NA 1.40) lenses under the control of LSM software (Carl Zeiss).
Coronal sections of cerebral cortices containing the labeled cells were classified into
CP and IZ, which were outer layer and middle layer, respectively. The number of
all labeled cells in each region was calculated. To evaluate the morphology of the
migrating neurons, projection images of EGFP-positive neurons were obtained
from Z-series confocal images using LSM software. At least three independent fetal
brains were electroporated and analyzed for each experiment. All experiments were
performed in a blinded manner.
Statistical analysis. Data are expressed as the mean± SEM. The sample size was
defined based on our previous reports12, 41 and G*Power 3.1 software. All statistical
analyses were performed with GraphPad Prism version 6 (GraphPad Software)
using Student’s t-tests (two-tailed), Dunnett’s tests, or Tukey’s multiple-
comparison tests. P< 0.01 and P< 0.05 were considered to indicate statistical
significance, and the effective size was calculated based on a previous report69. All
results of the statistical analysis are shown in Supplementary Table 2.
Data availability. The data that support the findings of this study are available
from the corresponding author on request.
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